Table 2 SLE patients, anti-IFNα autoantibodies and tuberculosis.
Anti-IFNα | Age at diagnosis | Gender | SLE Treatment at TB | TB involvement | Other infection | ||||
|---|---|---|---|---|---|---|---|---|---|
titer* | TB | SLE | Lung | LN | CNS | ||||
1 | < 3 | 20 | 42 | F | 0 | 1 | |||
2 | 65 | 49 | 53 | F | 0 | 1 | |||
3 | < 3 | 35 | 41 | F | 0 | 1 | Zona | ||
4 | < 3 | 37 | 35 | F | S, HCQ | 1 | |||
5 | 18 | 24 | 24 | F | 0 | 1 | |||
6 | 83 | 27 | 27 | F | 0 | 1 | |||
7 | 10 | 21 | 45 | F | 0 | 1 | 1 | ||
8 | < 3 | 64 | 63 | F | S, HCQ | 1 | |||
9 | < 3 | 52 | 53 | M | 0 | 1 | 1 | ||
